Navigation Links
First noiseless single photon amplifier
Date:11/12/2012

Research physicists have demonstrated the first device capable of amplifying the information in a single particle of light without adding noise.

The research collaboration, involving Griffith University, The University of Queensland and University of Science and Technology of China, was able to amplify the noisy quantum state of a single photon subjected to loss, without adding noise in the process; in fact, their amplification reduced the noise in the quantum state.

The results have been published today in "Heralded noiseless amplification of a photon polarization qubit", on the Nature Physics website.

Team leader, Professor Geoff Pryde from Griffith University's Centre for Quantum Dynamics said the breakthrough would provide a new tool for all sorts of new quantum technologies.

"This is the first time the information stored in a single photon has been amplified," Professor Pryde said.

"The technique works by combining the noisy quantum state with a 'clean' single photon in the amplifier, and using quantum teleportation to transfer the information onto the new photon.

"The most obvious application for this work is in improved quantum cryptography; secret messaging which is guaranteed secure by the laws of physics."

It is expected the results will stimulate further interest in the fundamental laws that govern how well amplifiers can work and in developing uses of noiseless amplification techniques for other quantum information technology applications.

Research into such applications is being pursued in Australia's Centre of Excellence for Quantum Computation and Communication Technology, as well as around the world. ​

Fellow team member Professor Tim Ralph from the University of Queensland said this breakthrough was the culmination of years of research.

"We have been developing the ideas and experimental techniques that led to this breakthrough for the past 4 years," Professor R
'/>"/>

Contact: Helen Wright
Helen.wright@griffith.edu.au
61-755-529-250
Griffith University
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology technology :

1. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2013 Financial Results
2. Elektas Monaco System Used for First Time to Create VMAT Plan for Delivery on Varian Treatment System
3. Palatin Technologies, Inc. To Report Fiscal Year 2013 First Quarter Results; Teleconference and Webcast to be held on November 14, 2012
4. First Neurally Controlled, Powered Prosthetic Limb Is 2,109 Steps Closer To Realization
5. Pharmacyclics Reports Fiscal 2013 First Quarter Financial Results and Multiple PCI-32765 Presentations at the 54th American Society of Hematology Annual Meeting
6. PAREXEL International Reports First Quarter Fiscal Year 2013 Results
7. Top Contenders For the First Annual 2012 Fright Night Awards Presented By Cancer Bites Announced
8. First-of-its-kind self-assembled nanoparticle for targeted and triggered thermo-chemotherapy
9. MRI Interventions and Brainlab Launch European Commercialization Effort with First ClearPoint Case in Europe
10. Texas Teacher May Be Among First Lone Star Astronauts
11. Penn researchers make first all-optical nanowire switch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 24, 2013 Die Übersetzungen wurden ... Bei der englischen Version handelt es ... % der Teilnehmer einer groß angelegten Asthmaumfrage halten ihren ... GINA [*] -Definition [1] als kontrolliert gelten können ... generell einer von vier Denkweisen zugeordnet werden können, die ...
(Date:5/23/2013)... stopped breathing, his collapsed bronchus blocking the crucial flow ... watched helplessly, just praying that somehow the dire predictions ... had a good chance of not leaving the hospital ... Kaiba. "At that point, we were desperate. Anything that ... it." , They found hope at the University of ...
(Date:5/23/2013)... Colo. , May 23, 2013 Venaxis, ... diagnostic company focused on obtaining FDA clearance and commercializing ... today announced the pricing of an underwritten public offering ... warrants to purchase 3,500,000 shares of its common stock ... a combined public offering price of $1.25 per share ...
(Date:5/23/2013)... , May 23, 2013  BioScrip, Inc. (NASDAQ: ... will present at the Jefferies 2013 Global Healthcare Conference ... Hyatt New York. Richard Smith ... Hai Tran , Chief Financial Officer, will ... Eastern Daylight Time.   About BioScrip ...
Breaking Biology Technology:Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 2Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 3Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 4Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 5Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 6Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 7Baby's life saved with groundbreaking 3-D printed device that restored his breathing 2Baby's life saved with groundbreaking 3-D printed device that restored his breathing 3Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3
... who have been dreaming of mobile devices that run ... wish has been granted. University of Illinois engineers ... is faster and uses 100 times less energy than ... devices much longer battery life between charges. Led ...
... Inc. (Nasdaq: MYL ) today announced that ... from the U.S. Food and Drug Administration (FDA) under ... its New Drug Application (NDA) for Zidovudine Tablets, 100 ... drug Retrovir® Tablets, by ViiV Healthcare. This pediatric antiretroviral ...
... (Nasdaq CM: INSMD), a biopharmaceutical company, today reported results ... 2010. Key Recent Highlights: ... 2011 with the FDA to begin a phase 3 ... non-TB Mycobacteria (NTM) lung infections. Successfully concluded 72 ...
Cached Biology Technology:New technology would dramatically extend battery life for mobile devices 2New technology would dramatically extend battery life for mobile devices 3Mylan's Matrix Receives FDA Approval Under PEPFAR for Zidovudine Tablets, 100 mg 2Insmed Announces Fourth Quarter and Full-Year 2010 Financial Results 2Insmed Announces Fourth Quarter and Full-Year 2010 Financial Results 3Insmed Announces Fourth Quarter and Full-Year 2010 Financial Results 4Insmed Announces Fourth Quarter and Full-Year 2010 Financial Results 5Insmed Announces Fourth Quarter and Full-Year 2010 Financial Results 6Insmed Announces Fourth Quarter and Full-Year 2010 Financial Results 7Insmed Announces Fourth Quarter and Full-Year 2010 Financial Results 8
(Date:5/23/2013)... Frontiers in Plant Science , ... gene content and promoter evolution among grasses , ... of stretches of DNA that undergo little change in ... not code for any proteins. Some of these evolutionarily ... to regulate the expression of other genes or the ...
(Date:5/23/2013)... fruit, can be made both better-tasting and longer-lasting thanks ... "Working with GM tomatoes that are different to normal ... allows us to pinpoint exactly how to breed in ... Innes Centre. , The research could also lead to ... characteristics because even higher levels of the compounds can ...
(Date:5/23/2013)... Laboratory honored more than 165 staff for their ... PNNL,s annual Intellectual Property Commercialization Recognition & Rewards ... national laboratory named materials scientist Jun Liu Inventor ... materials that can store large amounts of energy, ... the time it takes to charge cell phones, ...
Breaking Biology News(10 mins):Frontiers news briefs: May 23 2Frontiers news briefs: May 23 3The world's favorite fruit only better-tasting and longer-lasting 2PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2
... Institute, an NCI-designated cancer center at NYU Langone Medical ... Diffuse Large B-Cell Lymphoma (DLBCL), the most aggressive and ... published in the November 23 issue of Nature ... development of lymphomagenesis. "We have discovered that ...
... 28, 2011) -- Scientists at Weill Cornell Medical College used ... specially engineered for the study of cleft lip and cleft ... or treat the conditions in humans. Cleft lip and ... treatment requiring multiple cycles of surgery, speech therapy and orthodontics. ...
... published by Pensoft reported a substantial growth in 2011, ... jubilee 150th issue, By the end of November 2011, the ... compare with 4,962 pages and 180 articles in 2010). Since ... than 19,000 pages and 780 articles of valuable information on ...
Cached Biology News:New potential therapeutic target identified for Diffuse Large B-Cell Lymphoma 2Cleft lip corrected genetically in mouse model 2Cleft lip corrected genetically in mouse model 3Growth through innovations and open access: The journal ZooKeys on point for digital taxonomy 2
... Pichia Protocols is the first all-inclusive ... the Pichia pastoris Expression System. Methods developed ... provided as detailed, step-by-step protocols. This book ... expression vector, through strain construction and analysis, ...
Rad 51C Immunogen: His-tagged human Rad 51C, over-expressed in E. coli Storage: 4 C...
...
...
Biology Products: